Long considered a destination of choice for life science multinationals seeking to tap into the latent potential of Middle Eastern markets, the United Arab Emirates’ pharmaceuticals, medtech and healthcare sectors have all been exhibiting significant growth momentum in the post-pandemic period. “Thanks to its comparatively attractive operating environment and strong business fundamentals, the UAE…
Morocco is undergoing ambitious reforms, extending universal healthcare coverage to all its citizens while resolving the shortcomings laid bare during the COVID-19 pandemic. Endorsed by a USD 450 million Program-for-Results loan from the World Bank, the government’s plans have been well received by the country’s healthcare and life sciences stakeholders who shared their viewpoints in…
According to a recent report by IEIS, Turkey’s Pharmaceutical Manufacturers Association, there are approximately 680 companies competing in the country’s pharmaceutical industry. Together, they operate 96 pharmaceutical and 11 raw material production facilities. The industry employs over 40,000 people, exports to 180 countries, and produces more than 12 thousand products. Here is a snapshot…
From humble origins, taiba can now count on a unique two decades of experience in bringing innovative rare disease products to patients across the MENA region. The Dubai headquartered company, now branding itself as the partner of choice for rare diseases across the region, has also moved to create a local manufacturing footprint to better…